← Leaderboards
Jungwoo Lee
Massachusetts General Hospital
$3,464,788
Attributed
$3,464,788
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $396.3K · FY2012–25$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,464,788 · 4
By mechanism
R01$1,755,792 · 1
R33$790,767 · 1
R00$739,525 · 1
K99$178,704 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Alexander Georg Marneros$9,499,330
- Biju Parekkadan$9,663,657
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPreventPharmaceutical PreparationsBone MarrowStromal CellsTherapeutic TargetEngraftmentMolecularTissue EngineeringImplantTumorNeoplastic CellCancer BiologyScaffold3-DimensionalGrowthNeoplasm MetastasisBiocompatible MaterialsBlood VesselsPhenotypeCancer SurvivorStandardizationBiomedical EngineeringMonitor
Grant awards (12)
Develop and validate demineralized bone paper-based human bone metabolic and senolytic assays$396,285
R33 · FY2025 · CA · contact PI
Develop and validate demineralized bone paper-based human bone metabolic and senolytic assays$394,482
R33 · FY2024 · CA · contact PI
Implantable pre-metastatic niche to elucidate the impact of chemotherapy-induced metastatic relapse$343,973
R01 · FY2023 · CA · contact PI
Implantable pre-metastatic niche to elucidate the impact of chemotherapy-induced metastatic relapse$351,810
R01 · FY2022 · CA · contact PI
Implantable pre-metastatic niche to elucidate the impact of chemotherapy-induced metastatic relapse$352,305
R01 · FY2021 · CA · contact PI
Implantable pre-metastatic niche to elucidate the impact of chemotherapy-induced metastatic relapse$353,444
R01 · FY2020 · CA · contact PI
Implantable pre-metastatic niche to elucidate the impact of chemotherapy-induced metastatic relapse$354,260
R01 · FY2019 · CA · contact PI
Elucidating Essential Components of Bone Marrow Metastasis$248,999
R00 · FY2016 · CA · contact PI
Elucidating Essential Components of Bone Marrow Metastasis$248,999
R00 · FY2015 · CA · contact PI
Elucidating Essential Components of Bone Marrow Metastasis$241,527
R00 · FY2014 · CA · contact PI
Elucidating Essential Components of Bone Marrow Metastasis$89,352
K99 · FY2013 · CA · contact PI
Elucidating Essential Components of Bone Marrow Metastasis$89,352
K99 · FY2012 · CA · contact PI